Aetiology of genital ulcer disease in female partners of male participants in a circumcision trial in Uganda

International Journal of STD and AIDS

Volumn 20, Issue 9, 2009, Pages 650-651

  Brankin, A E ^a   Tobian, A A R ^b   Laeyendecker, O ^a,b   Suntoke, T R ^a   Kizza, A ^c   Mpoza, B ^c   Kigozi, G ^c   Nalugoda, F ^c   Iga, B ^c   Chen, M Z ^d   Gray, R H ^d   Wawer, M J ^d   Quinn, T C ^a,b   Reynolds, S J ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Circumcision; Genital ulcer disease (GUD); H. ducreyi (HD); Herpes simplex virus type 2 (HSV 2); HIV; T. pallidum (TP)

Indexed keywords

ARTICLE; CIRCUMCISION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENITAL ULCER; HAEMOPHILUS DUCREYI; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MALE; PRIORITY JOURNAL; SEROPREVALENCE; TREPONEMA PALLIDUM; UGANDA;

CIRCUMCISION, MALE; FEMALE; GENITAL DISEASES, FEMALE; HERPESVIRUS 2, HUMAN; HIV SERONEGATIVITY; HUMANS; MALE; SEXUAL PARTNERS; UGANDA; ULCER;

EID: 69949185398     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009067     Document Type: Article

References (13)

1. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS (London, England) 2006;20:73-83
2. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357:1149-1153 (Pubitemid 32378686)
3. Gray RH, Wawer MJ, Sewankambo NK, et al. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team. AIDS (London, England) 1999;13:2113-2123
4. Ahmed HJ, Mbwana J, Gunnarsson E, et al. Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two tanzanian cities. Sex Transm Dis 2003;30:114-119 (Pubitemid 36184357)
5. Tobian AAR, Ssempijja V, Oliver A, et al. Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda. AIDS 2004;25 [eprint ahead of press]
6. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007;369:657-666
7. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005;2:e298 (Pubitemid 41735779)
8. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369:643-656 (Pubitemid 46710115)
9. Tobian AAR, Serwadda D, Quinn TC, et al. Efficacy of male circumcision for HSV-2, syphilis and HPV prevention. N Engl J Med 2009;360:1298-1309
10. Gray RH, Kigozi G, Serwadda D, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2009;200:42 e1-7
11. Wawer M, Kigozi G, Serwadda D, et al. Trial of male circumcision in HIV+ men, Rakai, Uganda: effects in HIV+ men and in women partners. Fifteenth Conference on Retroviruses and Opportunistic Infections 2008: Abstract 33LB
12. Suntoke TR, Hardick A, Tobian AA, et al. Evaluation of multiplex real-time PCR for detection of H. ducreyi, T. pallidum, HSV-1, and HSV-2 in the diagnosis of genital ulcer disease in Rakai District, Uganda. Sex Transm Infect 2009;85:97-101
13. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999;353:525-535 (Pubitemid 29078422)